Insufficient scRNA-seq data for expression of FRAT1 at single-cell level.
Insufficient scRNA-seq data for expression of FRAT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 550.65 | 245 / 245 | 100% | 15.57 | 502 / 502 |
liver | 100% | 784.01 | 225 / 226 | 99% | 15.16 | 402 / 406 |
thymus | 99% | 291.18 | 648 / 653 | 99% | 8.87 | 599 / 605 |
uterus | 100% | 344.95 | 170 / 170 | 98% | 7.87 | 450 / 459 |
pancreas | 99% | 288.09 | 324 / 328 | 98% | 7.99 | 174 / 178 |
brain | 98% | 313.81 | 2587 / 2642 | 99% | 14.68 | 695 / 705 |
bladder | 100% | 299.33 | 21 / 21 | 96% | 7.05 | 486 / 504 |
breast | 98% | 342.74 | 452 / 459 | 98% | 10.24 | 1093 / 1118 |
intestine | 99% | 412.81 | 957 / 966 | 97% | 7.33 | 512 / 527 |
stomach | 99% | 361.36 | 354 / 359 | 97% | 7.38 | 278 / 286 |
lung | 98% | 483.02 | 566 / 578 | 95% | 7.13 | 1094 / 1155 |
ovary | 95% | 304.58 | 171 / 180 | 97% | 7.52 | 419 / 430 |
esophagus | 98% | 274.71 | 1417 / 1445 | 93% | 5.23 | 170 / 183 |
skin | 99% | 400.91 | 1792 / 1809 | 88% | 4.25 | 413 / 472 |
kidney | 96% | 224.00 | 85 / 89 | 88% | 4.14 | 790 / 901 |
adrenal gland | 98% | 364.95 | 254 / 258 | 84% | 5.15 | 194 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 8.10 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.35 | 29 / 29 |
spleen | 100% | 1625.65 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.05 | 1 / 1 |
adipose | 99% | 314.67 | 1186 / 1204 | 0% | 0 | 0 / 0 |
muscle | 93% | 184.11 | 743 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 7.57 | 41 / 45 |
peripheral blood | 90% | 4593.66 | 839 / 929 | 0% | 0 | 0 / 0 |
heart | 90% | 218.78 | 775 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 73% | 153.73 | 981 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046825 | Biological process | regulation of protein export from nucleus |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | FRAT1 |
Protein name | Proto-oncogene FRAT1 (Frequently rearranged in advanced T-cell lymphomas 1) (FRAT-1) |
Synonyms | |
Description | FUNCTION: Positively regulates the Wnt signaling pathway by stabilizing beta-catenin through the association with GSK-3. May play a role in tumor progression and collaborate with PIM1 and MYC in lymphomagenesis. . |
Accessions | ENST00000371021.5 Q92837 |